Volume | 10,878 |
|
|||||
News | - | ||||||
Day High | 0.409 | Low High |
|||||
Day Low | 0.3835 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Trevena Inc | TRVN | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.3978 | 0.3835 | 0.409 | 0.409 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
49 | 10,878 | $ 0.3978578 | $ 4,328 | - | 0.3227 - 3.28 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
11:07:19 | 2 | $ 0.392499 | USD |
Trevena Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
7.15M | 18.32M | - | 3.13M | -40.29M | -2.20 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Trevena News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TRVN Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.347 | 0.4199 | 0.3227 | 0.375099 | 184,625 | 0.06037 | 17.40% |
1 Month | 0.4556 | 0.46 | 0.3227 | 0.3901159 | 389,231 | -0.04823 | -10.59% |
3 Months | 0.6195 | 0.70 | 0.3227 | 0.4564529 | 215,468 | -0.21213 | -34.24% |
6 Months | 0.55 | 0.7693 | 0.3227 | 0.5167063 | 153,264 | -0.14263 | -25.93% |
1 Year | 0.625 | 3.28 | 0.3227 | 1.95 | 1,001,406 | -0.21763 | -34.82% |
3 Years | 43.125 | 55.00 | 0.3227 | 16.85 | 1,131,595 | -42.72 | -99.06% |
5 Years | 36.50 | 112.50 | 0.3227 | 40.12 | 1,936,356 | -36.09 | -98.88% |
Trevena Description
Trevena Inc is an American biotechnology company. The portfolio pipeline is focused on medicines targeting pain management: TRV734: oral medicine for moderate to severe pain; TRV250: oral medicine for migraines; and TRV027: treatment for acute heart failure. Its leading product is oliceridine (TRV130), a protein-based chemical meant to manage moderate to severe acute pain. |